Global influenza vaccine market to grow to $13.32B by 2030, driven by aging population and vaccine innovations

The global influenza vaccine market, valued at $8.96 billion in 2024, is projected to reach $13.32 billion by 2030 with a 7% annual growth rate. Growth is fueled by rising public health awareness, an expanding elderly population, government immunization programs, and ongoing vaccine research. Innovations in vaccine technology, including cell-based and mRNA vaccines, along with increased accessibility through public campaigns, are key drivers. North America leads the market, while Asia Pacific is expected to grow fastest, supported by large populations and improved healthcare infrastructure.